Page 29 - 83_03

Achievements and struggles in stem-cell investigation research Results in Asian Patients. Stem Cell Reports. 2015; 4:
860-72.
31. Ma H, Morey R, O’Neil RV, et al. Abnormalities in
human pluripotent cells due to reprogramming 44. Arai T, Arai F, Yamato M. Hyper Bio Assembler for
mechanisms. Nature 2014; 511: 177-83. 3D Cellular Systems. Springer Japan 2015; eBook
ISBN: 9784431552970.
32. Yamada M, Johannesson B, Sagi I, et al. Human
oocytes reprogram adult somatic nuclei of a type 1 45. Tsuji T (Ed.). Laboratory for Organ Regeneration,
diabetic to diploid pluripotent stem cells. Nature 2014; RIKEN Center for Developmental Biology, Kobe,
510: 533-6. Japan. “Organ Regeneration Based on Developmental
Biology”. Springer Singapur 2017; ISBN:
33. Yoshihara E, Z, CS, et al. ERR? Is Required for the 9789811037689.
Metabolic Maturation of Therapeutically Functional
Glucose-Responsive ß Cells. Cell Meabolism 2016; 46. Vacanti MP, Roy A, Cortiella J, Bonassar L, Vacanti
23: 622-34. CA. Identification and initial characterization of
spore-like cells in adult mammals. J Cell Biochem.
34. Spemann H, Mangold H. Induction of embryonic 2001; 80: 455-60.
primordia by implantation of organizers from a
different species. Roux's Arch Entw Mech. 1924; 100: 47. Yoshida M, Kijima M, Akita M, et al. Potent and
599-638. specific inhibition of mammalian histone deacetylase
both in vivo and in vitro by trichostatin A. J Biol
35. Oppenheimer SB. The Discovery of Noggin. The Chem. 1990; 265:17174-9.
American Biology Teacher 1995; 57: 264-6.
48. S, Kohda T, H, et al. Successful Serial Recloning in the
36. Lumsden AG, Davies AM. Earliest sensory nerve Mouse over Multiple Generations. Cell Stem Cell
fibres are guided to peripheral targets by attractants 2013; 12, 293-7.
other than nerve growth factor. Nature 1983; 306:
786-8. 49. a) Obokata H, WakayamaT, Sasai Y, Kojima K,
Vacanti MP, Niwa H, Yamato M, Vacanti CA.
37. Carrasco AE, McGinnis W, Gehring WJ, De Robertis Stimulus-triggered fate conversion of somatic cells
EM. Cloning of a Xenopus laevis gene expressed into pluripotency. Nature 2014; 505: 641-7. b)
during early embryogenesis that codes for a peptide Obokata H, Sasai Y, Niwa H, et al. Bidirectional
region homologous to Drosophila homeotic genes: developmental potential in reprogrammed cells with
implications for vertebrate development. Cell 1984; acquired pluripotency. Nature 2014; 505: 676-80.
37: 409-14.
50. a) Obokata H, Wakayama T, Sasai Y, et al. Retraction:
38. Sasai Y, Lu B, Steinbeisser H, Geissert, et al. Xenopus Stimulus-triggered fate conversion of somatic cells
chordin: a novel dorsalizing factor activated by into pluripotency. Nature 2014; 511: 112. b) Obokata
organizer-specific homeobox genes. Cell 1994; 79: H, Sasai Y, Niwa H, et al. Retraction: bidirectional
779-90. developmental potential in reprogrammed cells with
acquired pluripotency. Nature 2014; 511: 112.
39. a) Piccolo S, Sasai Y, Lu B, De Robertis EM.
Dorsoventral patterning in Xenopus: Inhibition of
ventral signals by direct binding of Chordin to BMP-
4. Cell 1996; 86: 589-98. b) Piccolo S, Agius E, Lu B,
et al. Cleavage of Chordin by the Xolloid
metalloprotease suggests a role for proteolytic
processing in the regulation of Spemann organizer
activity. Cell 1997; 91: 407-16. c) De Robertis EM.
Spemann's organizer and self-regulation in amphibian
embryos. Nat Rev Mol Cell Biol. 2006; 7: 296-302.

40. a) Stem cells: Human eye parts in a dish. Nature 2012;
486: 297.

b) Nakano T, Ando S, Takata N, et al. Self-formation of
optic cups and storable stratified neural retina from
human ESCs. Cell Stem Cell 2012; 10: 771- 85. c)
Cyranoski D. Nature News 2012: 10835.

41. Reardon S, Cyranoski D. Japan stem-cell trial stirs
envy. Nature 2014; 513: 287-8.

42. Mandai M, Watanabe A, Kurimoto Y, et al.
Autologous Induced Stem-Cell-Derived Retinal Cells
for Macular Degeneration. N Engl J Med 2017; 376:
1038-46.

43. Song WK, Park K-M, Kim H-J, et al. Treatment of
Macular Degeneration Using Embryonic Stem Cell-
Derived Retinal Pigment Epithelium: Preliminary

@Real Academia Nacional de Farmacia. Spain 331